Basics Mineralys Therapeutics, Inc. IPO Date: February 10, 2023 Sector: Healthcare Industry: Biotech Market Cap: $3.43B Activated in VL: True Average Daily Range Avg Daily Range: $0.41 | 2.92% Avg Daily Range (30 D): $0.98 | 2.51% Avg Daily Range (90 D): $0.72 | 3.10% Institutional Daily Volume Avg Daily Volume: .39M Avg Daily Volume (30 D): 1.19M Avg Daily Volume (90 D): 1.15M Trade Size Avg Trade Size (Sh.): 69 Avg Trade Size (Sh.) (30 D): 58 Avg Trade Size (Sh.) (90 D): 66 Institutional Trades Total Inst.Trades: 471 Avg Inst. Trade: $2.28M Avg Inst. Trade (30 D): $3.94M Avg Inst. Trade (90 D): $2.82M Avg Inst. Trade Volume: .11M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $3.11M Avg Closing Trade (30 D): $6.8M Avg Closing Trade (90 D): $3.96M Avg Closing Volume: 155.25K     News Sep 7, 2025 @ 12:23 PM These 2 Healthcare Stocks More Than Doubled Recent... Source: Cory Renauer Sep 5, 2025 @ 1:00 PM Mineralys Therapeutics Presents Subgroup Analyses ... Source: Mineralys Therapeutics Sep 3, 2025 @ 1:33 AM Mineralys Therapeutics Announces Pricing of Upsize... Source: Mineralys Therapeutics May 24, 2025 @ 8:30 AM Mineralys Therapeutics Announces Late-Breaking Pre... Source: Mineralys Therapeutics Mar 29, 2025 @ 6:30 PM Mineralys Therapeutics Announces Late-Breaking Dat... Source: N/A Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.66 $-.79 Diluted EPS $-.66 $-.79 Revenue $ $ M $ M Gross Profit $ $ $ Net Income / Loss $ $ -43.27M $ -42.21M Operating Income / Loss $ $ -46.75M $ -44.45M Cost of Revenue $ $ $ Net Cash Flow $ $ -63.22M $ 50.92M PE Ratio